- Home
- PULM vs FLUX Comparison
PULM vs FLUX Comparison
Compare PULM & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- FLUX
- Stock Information
- Founded
- PULM 2003
- FLUX N/A
- Country
- PULM United States
- FLUX United States
- Employees
- PULM N/A
- FLUX 119
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- FLUX Industrial Machinery/Components
- Sector
- PULM Health Care
- FLUX Miscellaneous
- Exchange
- PULM Nasdaq
- FLUX Nasdaq
- Market Cap
- PULM 33.2M
- FLUX 25.4M
- IPO Year
- PULM N/A
- FLUX N/A
- Fundamental
- Price
- PULM $6.68
- FLUX $2.16
- Analyst Decision
- PULM
- FLUX Strong Buy
- Analyst Count
- PULM 0
- FLUX 2
- Target Price
- PULM N/A
- FLUX $6.00
- AVG Volume (30 Days)
- PULM 63.0K
- FLUX 106.6K
- Earning Date
- PULM 08-12-2025
- FLUX 08-15-2025
- Dividend Yield
- PULM N/A
- FLUX N/A
- EPS Growth
- PULM N/A
- FLUX N/A
- EPS
- PULM N/A
- FLUX N/A
- Revenue
- PULM $1,921,000.00
- FLUX $63,074,000.00
- Revenue This Year
- PULM N/A
- FLUX $11.10
- Revenue Next Year
- PULM $134.88
- FLUX $12.66
- P/E Ratio
- PULM N/A
- FLUX N/A
- Revenue Growth
- PULM N/A
- FLUX N/A
- 52 Week Low
- PULM $1.78
- FLUX $1.15
- 52 Week High
- PULM $10.40
- FLUX $4.75
- Technical
- Relative Strength Index (RSI)
- PULM 41.92
- FLUX 75.98
- Support Level
- PULM $6.51
- FLUX $1.36
- Resistance Level
- PULM $6.96
- FLUX $2.53
- Average True Range (ATR)
- PULM 0.86
- FLUX 0.18
- MACD
- PULM -0.13
- FLUX 0.10
- Stochastic Oscillator
- PULM 44.61
- FLUX 80.34
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.